October 14, 2025
1 min read

BioNTech’s African mRNA vaccine production push gets EU funding boost

As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company’s efforts.

Leave a Reply

Your email address will not be published.

Previous Story

Novo plant hit with FDA’s most serious inspection classification, portending possible delays for partners

Next Story

LGBTQ+ clinicians hold the line, plan for future

Previous Story

Novo plant hit with FDA’s most serious inspection classification, portending possible delays for partners

Next Story

LGBTQ+ clinicians hold the line, plan for future

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop